APA (7th ed.) Citation

Cuker, A., Bass, A. D., Nadj, C., Agius, M. A., Steingo, B., Selmaj, K. W., . . . Jannsens, A. (2020). Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management. Multiple Sclerosis Journal, 26(1), 48. https://doi.org/10.1177/1352458518816612

Chicago Style (17th ed.) Citation

Cuker, Adam, et al. "Immune Thrombocytopenia in Alemtuzumab-treated MS Patients: Incidence, Detection, and Management." Multiple Sclerosis Journal 26, no. 1 (2020): 48. https://doi.org/10.1177/1352458518816612.

MLA (9th ed.) Citation

Cuker, Adam, et al. "Immune Thrombocytopenia in Alemtuzumab-treated MS Patients: Incidence, Detection, and Management." Multiple Sclerosis Journal, vol. 26, no. 1, 2020, p. 48, https://doi.org/10.1177/1352458518816612.